(Press-News.org) Imperial chemists have gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped.
The scientists hope their findings will help them to design drugs that could target the enzyme, known as N-myristoyltransferase (NMT), and potentially lead to new treatments for cancer and inflammatory conditions.
They have already identified a molecule that blocks NMT's activity, and have identified specific protein substrates where this molecule has a potent impact.
NMT makes irreversible changes to proteins and is known to be involved in a range of diseases including cancer, epilepsy and Alzheimer's disease.
In a study published in the journal Nature Communications chemists used living human cancer cells to identify more than 100 proteins that NMT modifies, with almost all these proteins being identified for the very first time in their natural environment.
The scientists mapped all of the proteins and also established that a small drug-like molecule can block the activity of NMT and inhibit its ability to modify each of these proteins, suggesting a potential new way to treat cancer.
Lead researcher Professor Ed Tate, from the Department of Chemistry at Imperial College London said: "We now have a much fuller picture of how NMT operates, and more importantly how it can be inhibited, than ever before. This is the first time that we have been able to look in molecular detail at how this potential drug target works within an entire living cancer cell, so this is a really exciting step forward for us."
"This 'global map' allows us to understand what the effects of inhibiting NMT will be. This means we can determine which diseases it might be possible to combat by targeting NMT, enabling us as a next step to explore how effective such treatments could be," added Professor Tate.
The researchers spent several years developing a specialised set of tools to identify and examine NMT and the proteins it changes. They began by conducting a detailed large scale study exploring proteins under the control of NMT, but the scientists still needed information on the function of these proteins and how they are modified.
Next they used mass spectrometry to quantify the effect of a NMT inhibitor molecule. To examine this interaction, they induced a process called apoptosis, which programmes a cell to die - for example because its DNA has been damaged. This process is essential in cancer chemotherapy, and is very often deactivated in drug resistant cancers. Until now scientists knew that NMT modified only a handful of protein during apoptosis, but the results of this study identified many new proteins affected by NMT, suggesting new ways to combat drug resistance.
Reflecting on the next stage of research, Professor Tate said: "On the back of these results we are looking to test a drug that will have the most potent impact on blocking NMT's ability to modify proteins, and we have started working with collaborators at the Institute of Cancer Research and elsewhere on some very promising therapeutic areas. We are still at an early stage in our research but we have already identified several very potent drug-like NMT inhibitors that are active in animal disease models, and we hope to move towards clinical trials over the next five to ten years."
INFORMATION:
This research was carried out in collaboration with the University of York, and was primarily funded by Cancer Research UK and The Biotechnology & Biological Sciences Research Council, with further support from The Medical Research Council, The Engineering and Physical Sciences Research Council, and the European Union.
Contact:
Gail Wilson
Research Media Officer - Faculty of Natural Sciences
Tel: +44 (0)20 7594 6702
Duty press officer mobile: +44 (0)7803 886248
Email: gail.wilson@imperial.ac.uk
Notes to editors:
1. Thinon, E. et al. "Global profiling of co- and post-translationally N-myristoylated proteomes in human cells" Nature Communications, September 2014.
Once embargo has lifted on Friday 26 September 2014 at 1000 London time (BST) / 0500 US Eastern Time, the paper can be downloaded at: http://dx.doi.org/10.1038/ncomm5919
2. About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.
In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.
Website: http://www.imperial.ac.uk
Protein 'map' could lead to potent new cancer drugs
2014-09-26
ELSE PRESS RELEASES FROM THIS DATE:
More than 70 percent of young oncologists in Europe suffer symptoms of burnout
2014-09-26
Across Europe, more than 70% of young cancer specialists are showing signs of burnout, the largest survey of its kind has revealed. The results, reported at the Congress of the European Society for Medical Oncology (ESMO 2014) in Madrid, have prompted calls for serious action to address the issue at all levels.
"Oncology is an exceptionally rewarding career, but it can be demanding and stressful at times," said Dr Susana Banerjee, lead author of the study and a consultant medical oncologist at The Royal Marsden NHS Trust in London, UK.
"Oncologists make complex decisions ...
The discovery of 27 vertebrates fully reveals the unmatched biodiversity in Tanzania
2014-09-26
A study by an international team of scientists coordinatedby Italy's MUSE - Science Museum updates knowledge on the faunal richness of the Eastern Arc Mountains of Tanzania and Kenya; presents the discovery of 27 new vertebrate species (of which 23 amphibians and reptiles); identifies the drivers of the area's exception biological importance and advocates for its candidature to the UNESCO's List of World Heritage Sites.
A study documenting the latest research findings on the faunal richness of the tropical moist forests of the Eastern Arc Mountains of Kenya and Tanzania ...
Turmeric compound boosts regeneration of brain stem cells
2014-09-26
A bioactive compound found in turmeric promotes stem cell proliferation and differentiation in the brain, reveals new research published today in the open access journal Stem Cell Research & Therapy. The findings suggest aromatic turmerone could be a future drug candidate for treating neurological disorders, such as stroke and Alzheimer's disease.
The study looked at the effects of aromatic (ar-) turmerone on endogenous neutral stem cells (NSC), which are stem cells found within adult brains. NSC differentiate into neurons, and play an important role in self-repair and ...
Talk therapy -- not medication -- best for social anxiety disorder, large study finds
2014-09-26
While antidepressants are the most commonly used treatment for social anxiety disorder, new research suggests that cognitive behavioral therapy (CBT) is more effective and, unlike medication, can have lasting effects long after treatment has stopped.
Social anxiety disorder is a psychiatric condition characterized by intense fear and avoidance of social situations and affects up to 13 percent of Americans and Europeans. Most people never receive treatment for the disorder. For those who do, medication is the more accessible treatment because there is a shortage of trained ...
Experts call for a moratorium on use of new internet domain .health
2014-09-26
As the Internet Corporation for Assigned Names and Numbers (ICANN) moves forward with plans to launch health-related generic top-level domains (gTLD), such as .health and .doctor, a coalition of health policy academics and clinicians are raising concerns about a process they say "favor[s] business interests and the generation of profits over the future integrity of the Health Internet."
In a commentary published in the open access journal Globalization and Health, the authors - led by Tim Mackey of the Global Health Policy Institute – call for a moratorium on use of ...
Viral infection in transplant recipients increases risk of developing damaging antibodies
2014-09-26
Washington, DC (September 25, 2014) — Kidney transplant recipients infected with BK virus are more likely to develop antibodies against their kidney transplants than uninfected patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Future treatment strategies should focus on simultaneously clearing BK infections while protecting against risks of transplant rejection.
Many people are infected with BK virus, and it rarely causes disease. However, for transplant recipients and others who take immunosuppressive ...
Not all Hispanics are the same when it comes to drinking
2014-09-25
Hispanics are often grouped into a single category when it comes to alcohol use. Yet a new Michigan State University study indicates that the risk of alcohol abuse and dependence can vary significantly among different subgroups within the population.
Using pre-existing national data which looked at the incident rate of alcohol use disorders, or AUDs, over a period of time, Carlos F. Ríos-Bedoya, an assistant professor in the College of Human Medicine, is the first to determine that the annual incidence rate isn't the same among all Hispanics and prevention efforts shouldn't ...
Gastric bypass bests banding for weight loss, diabetes, high blood pressure and cholesterol control
2014-09-25
DALLAS – Sept. 25, 2014 – Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a new review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures.
The review, appearing in JAMA, found that those undergoing gastric bypass operations lost more weight — an average of 66 percent of their excess weight, compared to 45 percent average excess weight loss for those undergoing ...
Bariatric surgery not a magic wand to curb depression
2014-09-25
Most severely obese people experience much better spirits once they shed weight through a diet, lifestyle changes or medical intervention. This is unfortunately not true for everyone, says Valentina Ivezaj and Carlos Grilo of the Yale University School of Medicine in the US. In an article in Springer's journal Obesity Surgery, the researchers advise that the levels of depression in patients be measured six to 12 months after they have had such bariatric surgery. This will ensure that the necessary help can be provided when needed.
Ivezaj and Grilo set out to investigate ...
Long-term unemployed struggle as economy improves, Rutgers study finds
2014-09-25
NEW BRUNSWICK, N.J. – While the unemployment rate for people out of work for six months or less has returned to prerecession levels, the levels of unemployment for workers who remain jobless for more than six months is among the most persistent, negative effects of the Great Recession, according to a new national study at Rutgers. In fact, one in five workers laid off from a job during the last five years are still unemployed and looking for work, researchers from the John J. Heldrich Center for Workforce Development found.
Among the key findings of "Left Behind: The ...